1DVA:BIT
Davita Inc
€168.00
arrow_upward
+2.82%(+4.60) 1D
May 20, 3:31:26 PM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 1DVA...
Mkt. cap
12.06B
Avg. vol.
35.00
Volume
0.00
52-wk high
€179.40
52-wk low
€88.62
No. of employees
78K
Mkt. cap
12.06B
Avg. vol.
35.00
Volume
0.00
52-wk high
€179.40
52-wk low
€88.62
No. of employees
78K
News stories
From sources across the web
DirectorsTalk Interviews
·
2 days ago
DaVita Inc. (DVA) Stock Analysis: High Return On Equity Highlights Investment Potential
Ad Hoc News
·
2 days ago
DaVita Inc stock (US23804L1035): shares ease near late-May levels
Profile
DaVita Inc., incorporated in Delaware and headquartered in Denver, provides kidney dialysis services through a network of 2,657 outpatient centers in the United States, serving 200,500 patients, and 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease, which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.
In 2025, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2025, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2025, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs.
The company is ranked 331st on the Fortune 500. Wikipedia
About Davita Inc
CEOJavier J. Rodriguez
Employees78K
Founded1992
HeadquartersDenver, Colorado, United States
SectorHealth care provider
Websitedavita.com
AI content may include mistakes. Learn more